Overview
Dutch medical device company Vicentra has raised an additional $13 million in its Series D funding round, totaling $98 million. The investment, led by ROM Utrecht Region and a consortium of Dutch investors, aims to enhance manufacturing capabilities and commercial operations for its Kaleido insulin patch pump, a compact alternative for diabetes management. CEO Tom Arnold highlighted plans to triple the European user base by 2026 and prepare for a U.S. launch.
Products
Loading...
Recent Deals
Investors: ROM Utrecht Region
Dutch medical device company Vicentra has raised an additional $13 million in its Series D funding round, totaling $98 million. The investment, led by ROM Utrecht Region and a consortium of Dutch investors, aims to enhance manufacturing capabilities and commercial operations for its Kaleido insulin patch pump, a compact alternative for diabetes management. CEO Tom Arnold highlighted plans to triple the European user base by 2026 and prepare for a U.S. launch.